日期: 2025-08-01
代码: 1952.HK
事件: 股东增减持（股东增减持）
TF Capital IV Ltd.于2025-08-01场外增持2256万股，每股均价69.7港元，最新持股数目2273万股，最新持股比例6.48% @#$ On 1 August 2025, Everest Medicines Limited (the “Company”) issued 22,561,000 shares to C-Bridge IV Investment Two Limited in a top-up placing pursuant to a placing and subscription agreement dated 25 July 2025. As a result, the interest of the relevant shareholder increased. For details, see the announcements of the Company dated 25 July and 1 August 2025.